Brief: China Biotech Services Says Strategic Cooperation Deal With Astrazeneca Investment (China)
Oct 18 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH ASTRAZENECA
INVESTMENT (CHINA)
* COMPANY AND ASTRAZENECA INVESTMENT (CHINA) ENTERED
STRATEGIC
COOPERATION FRAMEWORK AGREEMENT
* UNDER DEAL, PARTIES TO COOPERATE ON ENHANCEMENT, LICENSING
OF
IMMUNE CELL THERAPY, AMONG OTHERS
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)